Literature DB >> 2693036

Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA.

S Nomura1, B L Hogan, A J Wills, J K Heath, D R Edwards.   

Abstract

Single-stranded antisense RNA probes have been used to study the expression of the metalloproteinase inhibitor TIMP (tissue inhibitor of metalloproteinases), during mouse embryogenesis and in adult tissues. Using a sensitive RNase protection assay, low levels of transcript can be detected in a variety of tissues, including maternal deciduum, embryonic kidney, lung and amnion. Higher levels are seen in osteogenic tissues such as calvaria, while the highest level in any tissue is found in the ovary, though even here expression is an order of magnitude below that observed in growth factor-treated fibroblasts in vitro. Using the technique of in situ hybridization, TIMP transcripts can first be detected in osteogenic tissues in the head and limb at about 15.5 days post coitum, and increase in amount until birth. The high levels of TIMP RNA in the ovary are localized to cells of the corpora lutea.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693036     DOI: 10.1242/dev.105.3.575

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  15 in total

1.  Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene.

Authors:  David A Young; Blaine W Phillips; Caroline Lundy; Robert K Nuttall; Aileen Hogan; Gilbert A Schultz; Kevin J Leco; Ian M Clark; Dylan R Edwards
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 2.  Stromelysin-3 in the biology of the normal and neoplastic mammary gland.

Authors:  M C Rio; O Lefebvre; M Santavicca; A Noël; M P Chenard; P Anglard; J A Byrne; A Okada; C H Régnier; R Masson; J P Bellocq; P Basset
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

3.  Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development.

Authors:  L Blavier; Y A DeClerck
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

4.  Expression of the histamine H1 receptor gene in relation to atherosclerosis.

Authors:  T Takagishi; Y Sasaguri; R Nakano; N Arima; A Tanimoto; H Fukui; M Morimatsu
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

5.  Regional and temporal changes in the synthesis of matrix metalloproteinases and TIMP-1 during development of the rabbit mandibular condyle.

Authors:  J J Breckon; R M Hembry; J J Reynolds; M C Meikle
Journal:  J Anat       Date:  1994-02       Impact factor: 2.610

6.  The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse.

Authors:  C L Wilson; K J Heppner; L A Rudolph; L M Matrisian
Journal:  Mol Biol Cell       Date:  1995-07       Impact factor: 4.138

7.  The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

Authors:  R V Ward; R M Hembry; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

8.  Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.

Authors:  S Mohanam; S W Wang; A Rayford; M Yamamoto; R Sawaya; M Nakajima; L A Liotta; G L Nicolson; W G Stetler-Stevenson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

9.  Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells.

Authors:  O Kustikova; D Kramerov; M Grigorian; V Berezin; E Bock; E Lukanidin; E Tulchinsky
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 10.  Tumor invasion, proteolysis, and angiogenesis.

Authors:  U P Thorgeirsson; C K Lindsay; D W Cottam; D E Gomez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.